Proligerative retinopathies, such as proliferative diabetic retinoplathy and retinopathy of prematurity are common causes of blindness. Epidemiologic studies prpose an increase in diabetic patients over the coming years and thus the amount of people afrfected by proliferative retinopathy will also increase. Vascular endothelial growth factor (VEGF) has been identiefied as a key mo9lecular target in this desease and anti-VEGF drugs have found their way into the clinic, yet. The experiments presented in this thesis were performed to further investigate the molecular mechanisms of physiological and pathological retinal angiogenisis and to increase understanding of the pathogenenis of pathological neovascularization. Based on studies demonstrat...
Collectively, angiogenic ocular conditions represent the leading cause of irreversible vision loss i...
© 2019 Zoe Louise GrantThe expansion of blood vessel networks by angiogenesis is critical for matchi...
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer N...
Proligerative retinopathies, such as proliferative diabetic retinoplathy and retinopathy of prematur...
Proligerative retinopathies, such as proliferative diabetic retinoplathy and retinopathy of prematur...
Pathological angiogenesis of the retina is a key component of irreversible causes of blindness, as ...
Pathologic angiogenesis of the retina is a hallmark of frequent blinding conditions among the elderl...
An important character of the eye is transparency, so intraocular neovascularization, which is fragi...
Purpose: To investigate the mechanism of angiogenesis in proliferative diabetic retinopathy (PDR) an...
Funder: Deutsche Forschungsgemeinschaft; doi: http://dx.doi.org/10.13039/501100001659Funder: Technis...
AbstractIntraocular angiogenesis is considered the leading cause for severe loss of vision, and cont...
VEGFR1 and 2 signaling have both been increasingly shown to mediate complications of ischemic retino...
The present study was undertaken to test whether inhibition of the proangiogenic inflammatory cytoki...
Angiopoietin-2 (Ang-2) antagonises the maturing effect of angiopoietin-1 (Ang-1) on blood vessels, a...
Pigment epithelium-derived factor (PEDF) and tissue inhibitor of metalloproteinase-3 (TIMP-3) are th...
Collectively, angiogenic ocular conditions represent the leading cause of irreversible vision loss i...
© 2019 Zoe Louise GrantThe expansion of blood vessel networks by angiogenesis is critical for matchi...
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer N...
Proligerative retinopathies, such as proliferative diabetic retinoplathy and retinopathy of prematur...
Proligerative retinopathies, such as proliferative diabetic retinoplathy and retinopathy of prematur...
Pathological angiogenesis of the retina is a key component of irreversible causes of blindness, as ...
Pathologic angiogenesis of the retina is a hallmark of frequent blinding conditions among the elderl...
An important character of the eye is transparency, so intraocular neovascularization, which is fragi...
Purpose: To investigate the mechanism of angiogenesis in proliferative diabetic retinopathy (PDR) an...
Funder: Deutsche Forschungsgemeinschaft; doi: http://dx.doi.org/10.13039/501100001659Funder: Technis...
AbstractIntraocular angiogenesis is considered the leading cause for severe loss of vision, and cont...
VEGFR1 and 2 signaling have both been increasingly shown to mediate complications of ischemic retino...
The present study was undertaken to test whether inhibition of the proangiogenic inflammatory cytoki...
Angiopoietin-2 (Ang-2) antagonises the maturing effect of angiopoietin-1 (Ang-1) on blood vessels, a...
Pigment epithelium-derived factor (PEDF) and tissue inhibitor of metalloproteinase-3 (TIMP-3) are th...
Collectively, angiogenic ocular conditions represent the leading cause of irreversible vision loss i...
© 2019 Zoe Louise GrantThe expansion of blood vessel networks by angiogenesis is critical for matchi...
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer N...